Skip to main content
. 2019 Nov 6;16(22):4315. doi: 10.3390/ijerph16224315

Table 2.

Clinical and behavioral characteristics of patients.

Characteristics Poor Sleep Total p-Value
Yes No
n % n % n %
Ever injected drugs 64 61.0 188 64.8 252 63.8 0.48
Concurrent drug use 10 9.5 13 4.5 23 5.8 0.06
Frequency of alcohol drink in the last 30 days
No 57 54.3 127 43.7 184 56.6 0.14
Every few weeks 15 14.3 57 19.7 72 18.2
Every week 13 12.4 28 9.7 41 10.4
Daily 20 19.0 78 26.9 98 24.8
Frequency of smoking tobacco
No 29 27.6 46 15.9 75 19.0 0.07
Every few weeks 5 4.8 15 5.2 20 5.1
Every week 6 5.7 23 7.9 29 7.3
Daily 65 61.9 206 71.0 271 68.6
Missed any dose in the last 30 days 9 8.6 27 9.3 36 9.1 0.82
Mean SD Mean SD Mean SD
Age at onset of drug use 26.3 7.6 25.8 7.9 25.9 7.8 0.42
MMT duration (years) 3.1 2.2 2.7 2.2 2.8 2.2 0.06
MMT dose (mg) 70.3 50.8 68.8 30.6 69.2 37.0 0.34
MMT missed dose in the last 30 days 0.1 0.4 0.3 1.8 0.3 0.1 0.80
DASS-21 subscales
Depression 2.4 4.9 1.2 2.4 1.5 3.1 <0.01
Anxiety 4.8 4.5 3.1 3.6 3.6 3.9 <0.01
Stress 3.2 4.5 1.7 3.0 2.1 3.5 <0.01

MMT: Methadone Maintenance Treatment; DASS: Depression, Anxiety, and Stress Scale.